E7 TCR-T cells
192204
Phase 2 mab active
Quick answer
E7 TCR-T cells for Cervical Cancer is a Phase 2 program (mab) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iovance Biotherapeutics B.V.
- Indication
- Cervical Cancer
- Phase
- Phase 2
- Modality
- mab
- Status
- active